Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
FDA on Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
CDC on Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
Blogs on Supraventricular tachycardia AHA recommendations for Management of SVT in Pregnant Patients |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Vagal maneuvers, adenosine, and synchronized cardioversion is recommended for acute treatment in pregnant patients with SVT. Digoxinflecainide, metoprolol, propafenone, propranolol, sotalol, and verapamil alone or in combination, can be effective for ongoing management in pregnant patients with highly symptomatic SVT. Catheter ablation may be reasonable in pregnant patients with highly symptomatic, recurrent, drug-refractory SVT with efforts toward minimizing radiation exposure. Oral amiodarone may be considered for ongoing management in pregnant patients when treatment of highly symptomatic, recurrent SVT is required and other therapies are ineffective or contraindicated.[1]
Management of SVT in Pregnant Patients
2015 AHA recommendations for the acute and ongoing management of SVT in pregnant patients are described below:[1]
Acute treatment of SVT in pregnant patient
| Class I |
| "1. Vagal maneuvers are recommended for acute treatment in pregnant patients with SVT "(Level of Evidence:C-LD ) " |
| "2. Adenosine is recommended for acute treatment in pregnant patients with SVT "(Level of Evidence:C-LD ) " |
| "3. Synchronized cardioversion is recommended for acute treatment in pregnant patients with hemodynamically unstable SVT when pharmacological therapy is ineffective or contraindicated "(Level of Evidence:C-LD ) " |
| Class IIa |
| "1.bIntravenous metoprolol or propranolol is reasonable for acute treatment in pregnant patients with SVT when adenosine is ineffective or contraindicated "(Level of Evidence:C-LD ) " |
| Class IIb |
| "1. Intravenous verapamil may be reasonable for acute treatment in pregnant patients with SVT when adenosine and beta blockers are ineffective or contraindicated"(Level of Evidence:C-LD) " |
| "2. Intravenous procainamide may be reasonable for acute treatment in pregnant patients with SV "(Level of Evidence:C-LD) " |
| "3. Intravenous amiodarone may be considered for acute treatment in pregnant patients with potentially lifethreatening SVT when other therapies are ineffective or contraindicated "(Level of Evidence:C-LD) " |
Management of ongoing SVT in Pregnant Patients
| Class IIa |
| "1. The following drugs, alone or in combination, can be effective for ongoing management in pregnant patients with highly symptomatic SVT:
a. Digoxin, b. Flecainide, c. Metoprolol, d. Propafenone, e. Propranolol, f. Sotalol, g. Verapamil"(Level of Evidence:C-LD) " |
| Class IIb |
| "1. Catheter ablation may be reasonable in pregnant patients with highly symptomatic, recurrent, drug-refractory SVT with efforts toward minimizing radiation exposure "(Level of Evidence:C-LD) " |
| "2. Oral amiodarone may be considered for ongoing management in pregnant patients when treatment of highly symptomatic, recurrent SVT is required and other therapies are ineffective or contraindicated "(Level of Evidence:C-LD) " |
References
- ↑ 1.0 1.1 Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ; et al. (2016). "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol. 67 (13): e27–e115. doi:10.1016/j.jacc.2015.08.856. PMID 26409259.